Endonovo Therapeutics Inc (ENDV)

[John_Vallay]

Endonovo has $25.5 million in debt. That debt will never go away and it must be serviced. if the SEC is going to legally pursue the note holders and ultimately Endonovo will not be allowed to pay off the debt with convertible note conversions to common stock, I do not see how Endonovo will have the cash to purchase products to sell the products.

That 25 million is not going away and without conversion to common stock they will be faced with bankruptcy because they dont have money to buy products to sell products (ie generate revenues)

If they can pay off their debt with convertible note conversions then they can raise money to buy products to sell which will increase revenue, but that means a lot of dilution to stock holders which means another reverse split and we all know what happens to stock prices after a reverse split.

As for raising capital they are now using JH Darbie which I just read in the S1 offering.
WHO IS JH DARBIE and what type of deals do they do?